Journal of Clinical Medicine Article Influence of Androgen Receptor on the Prognosis of Breast Cancer 1, , 2, 1 2 3 Ki-Tae Hwang * y , Young A Kim y , Jongjin Kim , Jeong Hwan Park , In Sil Choi , Kyu Ri Hwang 4 , Young Jun Chai 1 and Jin Hyun Park 3 1 Department of Surgery, Seoul Metropolitan Government Seoul National University Boramae Medical Center, 39, Boramae-Gil, Dongjak-gu, Seoul 156-707, Korea;
[email protected] (J.K.);
[email protected] (Y.J.C.) 2 Department of Pathology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul 156-707, Korea;
[email protected] (Y.A.K.);
[email protected] (J.H.P.) 3 Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul 156-707, Korea;
[email protected] (I.S.C.);
[email protected] (J.H.P.) 4 Department of Obstetrics & Gynecology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul 156-707, Korea;
[email protected] * Correspondence:
[email protected]; Tel.: +82-2-870-2275; Fax: +82-2-831-2826 These authors contributed equally to this work. y Received: 28 February 2020; Accepted: 8 April 2020; Published: 10 April 2020 Abstract: We investigated the prognostic influence of androgen receptor (AR) on breast cancer. AR status was assessed using immunohistochemistry with tissue microarrays from 395 operable primary breast cancer patients who received curative surgery. The Kaplan–Meier estimator was used to analyze the survival rates and a log-rank test was used to determine the significance of the differences in survival. The Cox proportional hazards model was used to calculate the hazard ratio (HR) and the 95% confidence interval (CI) of survival.